INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 136 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $290,000 | -4.0% | 13,378 | -21.8% | 0.00% | 0.0% |
| Q2 2018 | $302,000 | -16.1% | 17,114 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $360,000 | +13.6% | 17,114 | -21.9% | 0.00% | 0.0% |
| Q4 2017 | $317,000 | -6.8% | 21,905 | +1.6% | 0.00% | 0.0% |
| Q3 2017 | $340,000 | -0.6% | 21,566 | -21.7% | 0.00% | 0.0% |
| Q2 2017 | $342,000 | +4.9% | 27,551 | +37.4% | 0.00% | 0.0% |
| Q1 2017 | $326,000 | +7.6% | 20,048 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $303,000 | +40.3% | 20,048 | +261.0% | 0.00% | +100.0% |
| Q2 2016 | $216,000 | -37.8% | 5,554 | -14.0% | 0.00% | -50.0% |
| Q4 2015 | $347,000 | -1.4% | 6,455 | -26.5% | 0.00% | 0.0% |
| Q3 2015 | $352,000 | -16.2% | 8,779 | -33.3% | 0.00% | -33.3% |
| Q2 2015 | $420,000 | +59.7% | 13,158 | +19.4% | 0.00% | +50.0% |
| Q1 2015 | $263,000 | – | 11,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |